We could not find any results for:
Make sure your spelling is correct or try broadening your search.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced today the acquisition of an extensive collection of issued and pending patents from...
-- Progen board; MELBOURNE, Australia, Feb. 19 /PRNewswire-FirstCall/ -- A general meeting of Progen Pharmaceuticals Ltd (ASX:PGL) shareholders was validly requisitioned on January 28, 2009 by...
Avexa Limited (?Avexa?) (ASX:AVX) today responds to an announcement by Cytopia Limited (?Cytopia?) (ASX:CYT) on 9 February 2009 which contains misleading statements about the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0.005 | 1.13636363636 | 0.44 | 0.45 | 0.435 | 161199 | 0.43993706 | DE |
52 | 0.075 | 20.2702702703 | 0.37 | 0.45 | 0.33 | 86776 | 0.42438704 | DE |
156 | -0.255 | -36.4285714286 | 0.7 | 1.085 | 0.27 | 60578 | 0.53643315 | DE |
260 | -1.285 | -74.2774566474 | 1.73 | 2.25 | 0.27 | 80695 | 0.81579705 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions